| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 33.65B | 32.81B | 32.70B | 31.49B | 29.89B |
| Gross Profit | 2.07B | 2.30B | 2.34B | 2.32B | 2.21B |
| EBITDA | 2.13B | 1.57B | 1.79B | 1.84B | 2.40B |
| Net Income | 384.00M | 242.00M | 137.00M | 207.00M | 677.00M |
Balance Sheet | |||||
| Total Assets | 18.94B | 24.65B | 25.06B | 26.39B | 27.15B |
| Cash, Cash Equivalents and Short-Term Investments | 1.07B | 727.00M | 2.00B | 1.81B | 1.02B |
| Total Debt | 6.60B | 6.61B | 6.55B | 7.14B | 7.38B |
| Total Liabilities | 12.79B | 18.00B | 18.19B | 19.13B | 18.73B |
| Stockholders Equity | 6.15B | 6.65B | 6.87B | 7.25B | 8.42B |
Cash Flow | |||||
| Free Cash Flow | 1.18B | 2.08B | 400.00M | 1.66B | 202.00M |
| Operating Cash Flow | 1.80B | 2.69B | 1.97B | 2.39B | 896.00M |
| Investing Cash Flow | -1.53B | -787.00M | -1.01B | -725.00M | -651.00M |
| Financing Cash Flow | -1.42B | -1.12B | -282.00M | -960.00M | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.81B | 8.36 | 14.71% | 2.06% | 6.96% | 28.47% | |
73 Outperform | £29.62B | 17.50 | 16.05% | 3.25% | 5.43% | 15.99% | |
68 Neutral | £1.52B | 5.67 | 20.47% | 3.34% | 6.79% | -20.45% | |
66 Neutral | £1.75B | 12.40 | 34.04% | 17.38% | 1.74% | -23.72% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | £7.00B | 9.02 | 6.12% | 4.02% | 2.54% | 12.99% | |
52 Neutral | £1.64B | -1.68 | 24.47% | ― | ― | ― |